Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Speech and pause characteristics in multiple sclerosis: A preliminary study of speakers with high and low neuropsychological test performance.
Perceived and actual arm performance in multiple sclerosis: relationship with clinical tests according to hand dominance.
Mechanics in Neuronal Development and Repair.
T Cell Apoptosis and Induction of Foxp3+ Regulatory T Cells Underlie the Therapeutic Efficacy of CD4 Blockade in Experimental Autoimmune Encephalomyelitis.
Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.
Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis.
Movement disorders in multiple sclerosis.
Simvastatin treatment does not protect retinal ganglion cells from degeneration in a rat model of autoimmune optic neuritis.
The grey matter correlates of impaired decision-making in multiple sclerosis.
Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature.
Anorexia heralding the onset of neuromyelitis optica.
Comment on Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin.
Factors related to difficulties with employment in patients with multiple sclerosis: a review of 2002-2011 literature.
A Standardized, Evidence-Based Massage Therapy Program for Decentralized Elite Paracyclists: Creating the Model.
Design and analysis of three-arm trials with negative binomially distributed endpoints.
Minocycline Hydrochloride (1818)
Mouse hepatitis virus infection upregulates genes involved in innate immune responses.
Sleep and oligodendrocyte functions.
Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.
Functional plasticity in MS: Friend or foe?
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study.
Prevalence of Lhermitte's sign in multiple sclerosis versus neuromyelitis optica.
Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force.
FTY720 protects neuronal cells from damage induced by human prion protein by inactivating the JNK pathway.
Features of neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies.
Pages
« first
‹ previous
…
265
266
267
268
269
270
271
272
273
…
next ›
last »